CXCL2 and neoplasm: Previous study showed that CAFs could mediate resistance to CSF-1R therapy by secreting CXCL1 and CXCL2 to recruit PMN-MDSCs, and the combined inhibition of CXCR2 and CSF-1R could overcome tumor resistance [36].